Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Microvesicles in the brain: Biomarker, messenger or mediator?
Diffusion tensor imaging of the trigeminal nerve in patients with trigeminal neuralgia due to multiple sclerosis.
Canonical Wnt Signaling in Dendritic Cells Regulates Th1/Th17 Responses and Suppresses Autoimmune Neuroinflammation.
[Genome-wide association study as a method for genetic architecture analysis in polygenic diseases (by the example of multiple sclerosis)].
Pallidal and caudate volumes correlate with walking function in multiple sclerosis.
Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.
Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome.
Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis.
Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients.
Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus.
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression.
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations.
Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.
Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait.
Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?
Bilateral claw hand: An uncommon presentation of regional Guillain-Barré syndrome.
Electrodiagnostics and clinical correlates in acquired polyneuropathies.
Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositivepatients in a Chinese population.
Rehabilitation of multiple sclerosis patients in India.
Systematic imaging review: Multiple Sclerosis.
MS Trust critical of guidance on multiple sclerosis.
Estrogen regulates excitatory amino acid carrier 1 (EAAC1) expression through sphingosine kinase 1 (SphK1) transacting FGFR-mediated ERK signaling in rat C6 astroglial cells.
Hyperhomocysteinemia and neurologic disorders: a review.
Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.
Serostatus of Epstein-Barr virus in Iranian MS patients.
Pages
« first
‹ previous
…
673
674
675
676
677
678
679
680
681
…
next ›
last »